Aktie A010600 WELLBIOTEC CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Wellbiotec Co., Ltd.

Aktien

A010600

KR7010600005

A010600

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 05.04.2024 		% 5 Tage % 1. Jan.
545 KRW -6.84% Intraday Chart für Wellbiotec Co., Ltd. -.--% -54.77%
08.04. Wellbiotec Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Wellbiotec Co., Ltd. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Wellbiotec Co., Ltd.(KOSE:A010600) dropped from S&P Global BMI Index
Wellbiotec Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Wellbiotec Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Wellbiotec Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Wellbiotec Co., Ltd. announced that it has received KRW 8.00000001 billion in funding from K-Impact Fund
Wellbiotec Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Wellbiotec Co., Ltd. announced that it has received KRW 3 billion in funding from KH Feelux Co., Ltd.
Wellbiotec Co., Ltd. announced that it has received KRW 10 billion in funding from Sangsangin Plus Savings Bank Co.,Ltd., Sangsangin Savings Bank, Investment Arm
Wellbiotec Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Sangsangin Plus Savings Bank Co.,Ltd., Sangsangin Savings Bank, Investment Arm
KOSSEN Co., Ltd. cancelled the acquisition of additional 14.57% stake in Biogenicskorea Co., Ltd. from a group of sellers.
Wellbiotec Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Wellbiotec Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Wellbiotec Co., Ltd. announced that it expects to receive KRW 3 billion in funding from KH Feelux Co., Ltd.
Wellbiotec Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Wellbiotec Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Wellbiotec Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Wellbiotec Co., Ltd. announced that it expects to receive KRW 9.99999891 billion in funding from Shin-oh Electronic Co.Ltd and another investor
Wellbiotec Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Wise Pacific Holdings Limited and another investor
Wellbiotec Co., Ltd. cancelled the transaction announced on January 2, 2019
Wellbiotec Co., Ltd. announced that it has received KRW 15 billion in funding
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A010600 Aktie
  4. Nachrichten Wellbiotec Co., Ltd.
  5. Andere Sprachen